Medicare Enrolled
Dr. Jan Kulhanek, MD
Cardiovascular Disease · Encinitas, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kulhanek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kulhanek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kulhanek
Dr. Jan Kulhanek is a cardiovascular disease specialist in Encinitas, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kulhanek performed 5,500 Medicare services across 3,781 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kulhanek received a total of $16,292 from 57 pharmaceutical and/or device companies across 665 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kulhanek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in CA
$16,292 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,500
Medicare services
Top 16% in CA for cardiovascular disease
3,781
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~275 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
1,270 | $7 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
832 | $102 | $231 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
405 | $166 | $455 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
402 | $76 | $600 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
377 | $12 | $36 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
360 | $43 | $204 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
201 | $387 | $1,058 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
201 | $54 | $154 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
140 | $168 | $443 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
121 | $779 | $1,583 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
118 | $20 | $55 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
108 | $98 | $218 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
99 | $135 | $345 |
| Telephone or internet consultation, more than 30 minutes A remote assessment conducted by a consulting physician via telephone or internet, lasting more than 30 minutes and including a verbal and written report. |
87 | $56 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
75 | $143 | $419 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
73 | $34 | $88 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
70 | $49 | $88 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
64 | $42 | $108 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
59 | $152 | $308 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
59 | $39 | $94 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
38 | $10 | $113 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
37 | $46 | $173 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
33 | $394 | $1,201 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
33 | $47 | $108 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
30 | $18 | $51 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
27 | $11 | $26 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
27 | $19 | $39 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
25 | $154 | $416 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
24 | $43 | $94 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
19 | $11 | $33 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
17 | $110 | $491 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
15 | $6 | $31 |
| Cardiac catheterization | 15 | $184 | $606 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
14 | $20 | $59 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
13 | $3 | $8 |
| Ultrasound of abdominal aorta An imaging test that uses sound waves to create pictures of the abdominal aorta, the large blood vessel that carries blood from the heart to the lower body. |
12 | $122 | $314 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.6% high complexity
24.8% medium
65.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,292
Total received (2018-2024)
Avg $2,327/year across 7 years
Top 21% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
665
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,292 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,229
2023
$2,485
2022
$3,012
2021
$1,002
2020
$589
2019
$2,716
2018
$4,260
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABIOMED
$233
Novartis Pharmaceuticals Corporation
$198
AstraZeneca Pharmaceuticals LP
$191
Amgen Inc.
$178
Esperion Therapeutics, Inc.
$160
Novo Nordisk Inc
$139
Kestra Medical Technology Services, Inc.
$138
iRhythm Technologies, Inc.
$120
CVRx, Inc.
$100
Merck Sharp & Dohme LLC
$96
Kiniksa Pharmaceuticals International, plc
$94
SANOFI-AVENTIS U.S. LLC
$83
Janssen Pharmaceuticals, Inc
$79
PFIZER INC.
$78
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$65
Medtronic, Inc.
$49
Lexicon Pharmaceuticals, Inc.
$48
Philips North America LLC
$24
Baxter Healthcare
$22
Boston Scientific Corporation
$22
Edwards Lifesciences Corporation
$21
Chiesi USA, Inc.
$21
Top 3 companies account for 27.9% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,992
SANOFI-AVENTIS U.S. LLC
$1,217
Novartis Pharmaceuticals Corporation
$1,129
PFIZER INC.
$1,092
Amgen Inc.
$924
AstraZeneca Pharmaceuticals LP
$872
E.R. Squibb & Sons, L.L.C.
$828
Janssen Pharmaceuticals, Inc
$672
Abbott Laboratories
$601
Merck Sharp & Dohme LLC
$550
Esperion Therapeutics, Inc.
$506
CVRx, Inc.
$447
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$443
Boehringer Ingelheim Pharmaceuticals, Inc.
$402
ABIOMED
$386
Actelion Pharmaceuticals US, Inc.
$353
Gilead Sciences, Inc.
$346
iRhythm Technologies, Inc.
$272
Otsuka America Pharmaceutical, Inc.
$270
Regeneron Healthcare Solutions, Inc.
$236
Medtronic, Inc.
$225
Kowa Pharmaceuticals America, Inc.
$204
Kiniksa Pharmaceuticals, Ltd.
$193
Medtronic Vascular, Inc.
$192
Amarin Pharma Inc.
$184
Novo Nordisk Inc
$183
Kestra Medical Technology Services, Inc.
$169
Bardy Diagnostics, Inc.
$137
Biosense Webster, Inc.
$135
Allergan Inc.
$128
Impulse Dynamics (USA) Inc.
$118
Kiniksa Pharmaceuticals International, plc
$94
Chiesi USA, Inc.
$89
HeartFlow, Inc.
$89
Lundbeck LLC
$72
Lexicon Pharmaceuticals, Inc.
$72
Merck Sharp & Dohme Corporation
$62
Daiichi Sankyo Inc.
$39
Lantheus Medical Imaging, Inc.
$29
BIOTRONIK INC.
$24
Braemar Manufacturing, LLC
$24
BOSTON SCIENTIFIC CORPORATION
$24
Philips North America LLC
$24
Baxter Healthcare
$22
Edwards Lifesciences Corporation
$21
AtriCure, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$21
Celgene Corporation
$18
W. L. Gore & Associates, Inc.
$18
AngioDynamics, Inc.
$18
Arrow Interventional, Inc.
$17
G Medical Diagnostic Services, Inc.
$16
Trevena, Inc.
$16
Amryt Pharma Holdings Ltd
$15
Lilly USA, LLC
$15
Itamar Medical Inc
$14
Tactile Systems Technology Inc
$13
Top 3 companies account for 26.6% of all-time payments
Associated products mentioned in payments ›
(CK4) MCOT · AMPLATZER AMULET · ANDEXXA · Abre · Allure CRT Pacemaker · Arcalyst · Assure WCD · Assurity Pacemaker · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOFORM Septal Occluder · CARDIOMEMS · CARTO 3 · CHANTIX · Cardiac Monitoring Suite · CardioMEMS HF System · Carnation Ambulatory Monitor · Catheter - GuideLiner · Confirm Rx · Corlanor · Definity · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · FARXIGA · FLEXITOUCH · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · Impella · Inpefa · JARDIANCE · Juxtapid · KENGREAL · Kerendia · LATITUDE · LEQVIO · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MITRACLIP · MULTAQ · MYCARELINK · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Olinvyk · Optimizer · Orsiro Mission · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Rybelsus · SAMSCA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRULICITY · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · VenaCure 1470 Pro · WAINUA · WATCHMAN · WATCHMAN FLX · WatchPAT · XARELTO · ZIO Patch · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
224
Per 100K population
6.8
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL - ENCINITAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kulhanek is a clinical cardiology specialist, with above-average Medicare volume (top 16% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kulhanek experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Kulhanek performed 1,270 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kulhanek receive payments from pharmaceutical companies?
Yes. Dr. Kulhanek received a total of $16,292 from 57 companies across 665 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kulhanek's costs compare to other cardiologists in Encinitas?
Dr. Kulhanek's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kulhanek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Encinitas
Browse cardiologists in Encinitas ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology